Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.
Follow-Up Questions
Cargo Therapeutics LLC のCEOは誰ですか？
Mr. Kevin Tang は Cargo Therapeutics LLC の Chief Executive Officer で、2025 から在籍しています。
CRGX の株価パフォーマンスは？
CRGX の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Cargo Therapeutics LLC の主な事業テーマや業界は？
Cargo Therapeutics LLC は Biotechnology 業界、セクターは Health Care に属しています。
